Perspective Therapeutics, Inc.
CATXNYSECIK 728387HealthcareFiscal year ends Dec 31
Reports and events: 400 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2310:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429770 |
| 2026-10-0810:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417384 |
| 2026-10-0120:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-410663 |
| 2026-09-2316:19 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-399446 |
| 2026-09-1410:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389785 |
| 2026-09-0821:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-385362 |
| 2026-09-0416:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-383775 |
| 2026-08-1020:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342512 |
| 2026-08-1020:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342495 |
| 2026-08-0320:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-330599 |
| 2026-07-0120:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-292547 |
| 2026-06-0110:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-249594 |
| 2026-05-2720:20 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-241940 |
| 2026-05-2222:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234991 |
| 2026-05-1120:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-216790 |
| 2026-05-1120:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216777 |
| 2026-05-0420:43 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-204161 |
| 2026-04-2010:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-162578 |
| 2026-04-1620:10 ET | DEF 14A | Proxy statementPeriod 2026-04-15 | 0001193125-26-159005 |
| 2026-04-0120:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-137930 |
| 2026-03-1620:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000728387-26-000004 |
| 2026-03-1620:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000728387-26-000003 |
| 2026-02-0321:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-035508 |
| 2026-02-0212:44 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-032706 |
| 2026-01-1412:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-012259 |
| 2026-01-1213:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009846 |
| 2026-01-0912:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-008277 |
| 2025-12-0121:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-303895 |
| 2025-11-1021:23 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274328 |
| 2025-11-1021:20 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-274318 |
| 2025-11-0613:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-268124 |
| 2025-11-0321:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-262636 |
| 2025-10-2010:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242912 |
| 2025-10-0111:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-225858 |
| 2025-09-0411:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000728387-25-000013 |
| 2025-09-0311:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000728387-25-000010 |
| 2025-09-0211:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000728387-25-000006 |
| 2025-08-1311:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107619 |
| 2025-08-1310:45 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-107609 |
| 2025-08-0120:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-101414 |
| 2025-07-0312:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-093556 |
| 2025-06-2310:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088700 |
| 2025-06-0312:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-080568 |
| 2025-05-3021:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-079876 |
| 2025-05-2821:23 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-078439 |
| 2025-05-1220:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069314 |
| 2025-05-1220:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-069301 |
| 2025-05-0121:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-061994 |
| 2025-04-2911:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-059557 |
| 2025-04-1620:30 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000950170-25-054776 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.